financetom
Business
financetom
/
Business
/
How Facebook name change fired up this Canadian company's stock
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
How Facebook name change fired up this Canadian company's stock
Nov 1, 2021 12:16 PM

Facebook recently announced its decision to rebrand as Meta, a name that signifies the growing ambition of its CEO Mark Zuckerberg to establish a metaverse. The company’s formerly eponymous social media platform will continue to be called Facebook. The parent company will be known as Meta Platforms Inc from December, with the company’s stock ticker being changed to MVRS.

Share Market Live

NSE

But this change has led to a sudden increase in the trading of a Canadian materials company. The Nova Scotia-based company saw its shares gain 26 percent after the announcement and trading volume increased to 12 million shares, double the average, reported CBC. The reason behind the jump is the company’s name and ticker; Meta Materials and MMAT.

Also read: Facebook rebrands to Meta, will trade as MVRS. Here’s why end of FAANG and FB is big deal

Meta Materials was the latest beneficiary of an all-too-common mistake. Investors jumped on to shares of Meta Materials in the mistaken belief that these were the shares of Meta Platforms Inc. The company makes materials for different industries, including aerospace and consumer electronics.

Smaller companies often end up benefitting in the short term when traders mistakenly buy their shares, though the shares often experience a sharp decline in prices when the investors realise their mistakes. And it is not just retail investors who make the mistake, hedge fund managers, portfolio managers and more are just as prone to human error as the rest.

Also read: Metaverse: Big Tech has its heart set on this “next big thing”, but what is it?

A 2019 paper by researchers working at Rutgers University found over 250 instances of price fluctuations in stock prices of companies that occurred as a result of various events happening at companies with similar names or ticker symbols.

"Something happens with a big company, and then there will be a reaction in the small company

Also read: Facebook changes name to Meta as it refocuses on virtual reality

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
IATA expects sustainable aviation fuel production to double in 2025
IATA expects sustainable aviation fuel production to double in 2025
Jun 1, 2025
SEOUL, June 1 (Reuters) - The International Air Transport Association said on Sunday it expects the amount of sustainable aviation fuel produced to double in 2025 to reach 2 million tonnes, representing 0.7% of airlines' fuel consumption. Influential industry body IATA has increasingly been warning that airlines will struggle to meet their sustainability goals, and has described the production of...
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Jun 1, 2025
* Therapy shrank tumors in 62% of patients in small trial * Result was not lasting beyond a few months for most patients * We're on the right track, scientist says By Julie Steenhuysen CHICAGO, June 1 (Reuters) - A Gilead Sciences ( GILD )-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients...
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
Jun 1, 2025
CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's ( AZN ) experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding that could change the way such cancers are treated, cancer experts said on Sunday. The results, presented at the American Society of Clinical Oncology meeting...
Copyright 2023-2026 - www.financetom.com All Rights Reserved